Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer, May 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 213 articles:
HTML format


 

Single Articles

  1. YAMAN M, Ozcan HEA, Bakir A
    High-Risk Human Papilloma Virus Genotype Distribution and Correlation with Cervical Cytomorphological Data in Turkish and Immigrant Women in Mersin Province.
    New Microbiol. 2024;47:88-97.
    PubMed    
    Abstract available

  2. XUE X, Pan Y, Li C
    Circ_TMCO3 Inhibits the Progression of Cervical Cancer by Activating FRMD6 Expression by Restraining miR-1291.
    Reprod Sci. 2024 May 3. doi: 10.1007/s43032-024-01549.
    PubMed    
    Abstract available

  3. ALREFAI EA, Alhejaili RT, Haddad SA
    Human Papillomavirus and Its Association With Cervical Cancer: A Review.
    Cureus. 2024;16:e57432.
    PubMed    
    Abstract available

  4. LEFEUVRE C, De Pauw H, Le Duc Banaszuk AS, Pivert A, et al
    Corrigendum: Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.
    Int J Public Health. 2024;69:1607299.
    PubMed    
    Abstract available

  5. KHURANA S, Smolar I, Warren L, Velasquez J, et al
    Time Differences From Abnormal Cervical Cancer Screening to Colposcopy Between Insurance Statuses.
    J Low Genit Tract Dis. 2024 May 2. doi: 10.1097/LGT.0000000000000812.
    PubMed    
    Abstract available

  6. VUKOMANOVIC IS, Kocic S, Vukomanovic V, Janicijevic K, et al
    Assessment of Sexual Health and Use of Cervical Cancer Screening among the Female Working Population.
    Iran J Public Health. 2024;53:198-207.
    PubMed    
    Abstract available

  7. BALAN L, Cimpean AM, Secosan C, Sorop VB, et al
    Heterogeneity of Cervical Cancer-Associated Tertiary Lymphoid Structures (TLSs) and Their Specific Interrelation With Clinicopathological Parameters.
    Cureus. 2024;16:e59077.
    PubMed    
    Abstract available

  8. ZHANG R, Xu W, Yang S, Hu D, et al
    Correction: Prevalence of High-Risk Human Papillomavirus Infection, Associated Risk Factors, and Relationship With Cervical Precancerous Lesions in Perimenopausal and Older Women in an Area With High Cervical Cancer Incidence in China.
    Cureus. 2024;16:c171.
    PubMed    
    Abstract available

  9. SHANKAR A, Sehra D, Roy S
    Cervical cancer advocacy: needs more than faking death.
    Lancet Reg Health Southeast Asia. 2024;25:100411.
    PubMed    


  10. SHRATEH ON, Habib A, Jalamneh B, Omar BMM, et al
    The level of medical students' knowledge regarding the prevention of cervical cancer.
    Ann Med Surg (Lond). 2024;86:2591-2597.
    PubMed    
    Abstract available

  11. MUKSIMOVA S, Umirzakova S, Kang S, Cho YI, et al
    CerviLearnNet: Advancing cervical cancer diagnosis with reinforcement learning-enhanced convolutional networks.
    Heliyon. 2024;10:e29913.
    PubMed    
    Abstract available

  12. ARROYO MUHR LS, Gini A, Yilmaz E, Hassan SS, et al
    Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer.
    Nat Commun. 2024;15:3679.
    PubMed    
    Abstract available

  13. LIU H, Liu Y, Zhou Y, Chen X, et al
    TM7SF2-induced lipid reprogramming promotes cell proliferation and migration via CPT1A/Wnt/beta-Catenin axis in cervical cancer cells.
    Cell Death Discov. 2024;10:207.
    PubMed    
    Abstract available

  14. TSONEVA E, Dimitrova P, Metodiev M, Shivarov V, et al
    Utility of expression of 4-hydroxynonenal tested by immunohistochemistry for cervical cancer.
    Prz Menopauzalny. 2024;23:6-13.
    PubMed    
    Abstract available

  15. ABBAS K, Yoo KJ, Prem K, Jit M, et al
    Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study.
    EClinicalMedicine. 2024;70:102524.
    PubMed    
    Abstract available

  16. CHEN W, Xie X, Liu C, Liao J, et al
    IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development.
    Cell Signal. 2024;119:111192.
    PubMed    
    Abstract available

  17. ZHANG W, Yin Y, Jiang Y, Yang Y, et al
    Relationship between vaginal and oral microbiome in patients of human papillomavirus (HPV) infection and cervical cancer.
    J Transl Med. 2024;22:396.
    PubMed    
    Abstract available

  18. LIU S, Gu Y, Shi Y, Yu S, et al
    AEBP1 upregulation contributes to cervical cancer progression by facilitating cell proliferation, migration, and invasion.
    J Obstet Gynaecol Res. 2024 Apr 29. doi: 10.1111/jog.15959.
    PubMed    
    Abstract available

  19. ARROSSI S, Binder F, Ituarte C, Martiarena N, et al
    [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
    Medicina (B Aires). 2024;84:236-248.
    PubMed    
    Abstract available

  20. BRUERA S, Bowman S, Huang Y, Suarez-Almazor ME, et al
    Factors associated with adherence of cervical cancer screening in women with Systemic Lupus Erythematosus.
    Arthritis Care Res (Hoboken). 2024 Apr 29. doi: 10.1002/acr.25355.
    PubMed    
    Abstract available

  21. NGWIBETE A, Ogunbode O, Swende LT, Agbada MM, et al
    Prevalence of precancerous lesions and other cervical abnormalities among internally displaced women in Benue State Nigeria.
    Pan Afr Med J. 2024;47:50.
    PubMed    
    Abstract available

  22. SHEASHEA AA, Ahmed FA, El Zayat E, Ebeed BW, et al
    In Vitro Antiviral and Anticancer Effects of Tanacetum sinaicum Essential Oil on Human Cervical and Breast Cancer.
    Asian Pac J Cancer Prev. 2024;25:1457-1471.
    PubMed    
    Abstract available

  23. ALIM S, Siddiqui SA, Akram M, Hakim S, et al
    A Comparative Study of Clinical Outcomes in Locally Advanced Cervical Cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A T
    Asian Pac J Cancer Prev. 2024;25:1333-1338.
    PubMed    
    Abstract available

  24. DEWI SM, Bennett LR, Barrett A
    Exploring Indonesian Primary Schoolgirls' Experiences of School-based HPV Vaccination, Knowledge of HPV Risks and Prevention, and Preferences for Cervical Cancer Education.
    Asian Pac J Cancer Prev. 2024;25:1285-1292.
    PubMed    
    Abstract available

  25. CHAOPOTONG P, Laiwejpithya S, Areeswate C
    Prevalence of High-Risk HPV Detection and HPV Vaccination in Cervical Cancer Screening During the HPV Vaccination Era at Siriraj Hospital - Thailand's Largest National Tertiary Referral Center.
    Asian Pac J Cancer Prev. 2024;25:1241-1245.
    PubMed    
    Abstract available

  26. MARZBANRAD Z, Karimi-Zarchi M, Noei-Teymoordash S, Motamedinasab M, et al
    A Comprehensive Integration of Data Regarding the Correlation of TNF-alpha rs1800629 Polymorphism with Susceptibility to Cervical Cancer.
    Asian Pac J Cancer Prev. 2024;25:1155-1167.
    PubMed    
    Abstract available

  27. TIAN Q, Huang J, Zhang Q, Zhao J, et al
    N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
    Clin Exp Pharmacol Physiol. 2024;51:e13864.
    PubMed    
    Abstract available

  28. RIGBY S, Greenley R, Uuskula A, Tisler A, et al
    Expanding eligibility and improving quality of cervical cancer screening in Estonia: The 2021 reforms.
    Health Policy. 2024;144:105077.
    PubMed    
    Abstract available

  29. TAKAC I, Kavalar R, Lovrec MR, Lovrec VG, et al
    Concomitant ectopic Enterobius vermicularis infection in uterine cervical cancer.
    BMC Womens Health. 2024;24:265.
    PubMed    
    Abstract available

  30. KIRABIRA J, Kayondo M, Bawakanya SM, Nsubuga EJ, et al
    Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
    BMC Womens Health. 2024;24:266.
    PubMed    
    Abstract available

  31. YAMAOKA Y, Tamura S, Yamanoi K, Taki M, et al
    Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma.
    Anticancer Res. 2024;44:2009-2019.
    PubMed    
    Abstract available

  32. JUNG BC, Woo SH, Kim SH, Kim YS, et al
    Parkin Enhances Gefitinib-induced Anoikis in HeLa Cervical Cancer Cells.
    Anticancer Res. 2024;44:1853-1862.
    PubMed    
    Abstract available

  33. WILLSON CM, Lequio M, Zhu Z, Wakefield MR, et al
    The Role of SARS-CoV-2 Spike Protein in the Growth of Cervical Cancer Cells.
    Anticancer Res. 2024;44:1807-1815.
    PubMed    
    Abstract available

  34. KUM SJ, Jung YY, Kim HS
    Comparison of Clinicopathological and Prognostic Characteristics Between Minimal Deviation Adenocarcinoma and Gastric-type Endocervical Adenocarcinoma.
    Anticancer Res. 2024;44:2193-2204.
    PubMed    
    Abstract available

  35. WANG J, Liu S, Wei B, Liu Y, et al
    Frequency shift Raman-based sensing of serum MicroRNA for ultrasensitive cervical cancer diagnosis.
    Photodiagnosis Photodyn Ther. 2024;46:104105.
    PubMed    
    Abstract available

  36. PESUT E, Simic I, Fures R, Milutin Gasperov N, et al
    Monitoring HPV Prevalence and Risk Cofactors for Abnormal Cytology in the Post-Vaccination Period among Croatian Women.
    Viruses. 2024;16:642.
    PubMed    
    Abstract available

  37. D'AMATO A, Riemma G, Agrifoglio V, Chiantera V, et al
    Reproductive Outcomes in Young Women with Early-Stage Cervical Cancer Greater than 2 cm Undergoing Fertility-Sparing Treatment: A Systematic Review.
    Medicina (Kaunas). 2024;60:608.
    PubMed    
    Abstract available

  38. LEE SM, Seol A, Cho HW, Min KJ, et al
    Optimal Dietary Intake of Riboflavin Associated with Lower Risk of Cervical Cancer in Korea: Korean National Health and Nutrition Examination Survey 2010-2021.
    Life (Basel). 2024;14:529.
    PubMed    
    Abstract available

  39. CHOI Y, Lee D, Kim NY, Seo I, et al
    Role of Tumor-Associated Macrophages in Cervical Cancer: Integrating Classical Perspectives with Recent Technological Advances.
    Life (Basel). 2024;14:443.
    PubMed    
    Abstract available

  40. STANIEWSKA E, Grudzien K, Stankiewicz M, Raczek-Zwierzycka K, et al
    The Prognostic Value of the Systemic Immune-Inflammation Index (SII) and Red Cell Distribution Width (RDW) in Patients with Cervical Cancer Treated Using Radiotherapy.
    Cancers (Basel). 2024;16:1542.
    PubMed    
    Abstract available

  41. NIU J, Chen Y, Chai HC, Sasidharan S, et al
    Exploring MiR-484 Regulation by Polyalthia longifolia: A Promising Biomarker and Therapeutic Target in Cervical Cancer through Integrated Bioinformatics and an In Vitro Analysis.
    Biomedicines. 2024;12:909.
    PubMed    
    Abstract available

  42. CHIZYUKA NA, Crawford E, Hebert KS, Gaju S, et al
    Lessons From the Design and Rollout of an Electronic Medical Record System for Cervical Cancer Screening in Rwanda.
    Glob Health Sci Pract. 2024 Apr 26. doi: 10.9745/GHSP-D-23-00469.
    PubMed    
    Abstract available

  43. YIN X, Liu X, Gong H, Chu Z, et al
    LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling.
    J Gynecol Oncol. 2024 Apr 19. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  44. WANG H, Wang D, Xu Y
    Exonuclease-iii -propelled DNAzyme cascade for sensitive and reliable cervical cancer related miRNA analysis.
    Anal Biochem. 2024;691:115547.
    PubMed    
    Abstract available

  45. JANJUA D, Thakur K, Aggarwal N, Chaudhary A, et al
    Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
    Crit Rev Oncol Hematol. 2024;197:104346.
    PubMed    
    Abstract available

  46. KINSLOW CJ, DeStephano DM, Neugut AI, Taparra K, et al
    Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
    JNCI Cancer Spectr. 2024;8:pkae022.
    PubMed    
    Abstract available

  47. STROETMANN CY, Gizaw M, Alemayehu R, Wondimagegnehu A, et al
    Adherence to Treatment and Follow-Up of Precancerous Cervical Lesions in Ethiopia.
    Oncologist. 2024;29:e655-e664.
    PubMed    
    Abstract available

  48. HUR CE, Goldberg JM
    Laparoscopic transfundal approach to cervical dilation: a novel treatment for cervical stenosis and cervical factor infertility.
    Fertil Steril. 2024;121:890-891.
    PubMed    
    Abstract available

  49. BOGANI G, Sopracordevole F, Ciavattini A, Vizza E, et al
    HPV persistence after cervical surgical excision of high-grade cervical lesions.
    Cancer Cytopathol. 2024;132:268-269.
    PubMed    


  50. ZHU Z, Lu J
    Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.
    Medicine (Baltimore). 2024;103:e38116.
    PubMed    
    Abstract available

  51. XIONG J, Chen P, He L, Chai X, et al
    Functional mechanism of hypoxia-like conditions mediating resistance to ferroptosis in cervical cancer cells by regulating KDM4A SUMOylation and the SLC7A11/GPX4 pathway.
    Environ Toxicol. 2024 May 10. doi: 10.1002/tox.24304.
    PubMed    
    Abstract available

  52. PASQUIER C, Raymond S, Carcenac R, Demmou S, et al
    HPV genotyping in clinical samples using long-read single-molecule real-time sequencing.
    J Med Virol. 2024;96:e29652.
    PubMed    
    Abstract available

  53. FAN C, Hu J, Luo T, Dong B, et al
    Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
    J Med Virol. 2024;96:e29521.
    PubMed    
    Abstract available

  54. EHMAN KM, Jenkins GD, Grimm JA, Cammack TL, et al
    Primary Human Papillomavirus Test Uptake and Cervical Cancer Screening Trends in the Midwest, United States.
    J Prim Care Community Health. 2024;15:21501319241251934.
    PubMed    
    Abstract available

  55. MA Z, Zhang H, Wang Y, Zhao H, et al
    Circular RNA circIL21R promotes cervical cancer cells proliferation and migration by sponging the miR-1205/PTBP1 axis.
    Am J Cancer Res. 2024;14:1730-1746.
    PubMed    
    Abstract available

  56. VANINOV A, Ibraimova D, Sharshenbaeva A, Zhumabekova A, et al
    Trends in the Prevalence and Mortality of Cervical Cancer in the Kyrgyz Republic.
    Cureus. 2024;16:e57863.
    PubMed    
    Abstract available

  57. AGUIAR-ROSAS S, Plancarte-Sanchez R, Hernandez-Porras BC, Garcia-Andreu J, et al
    Pain management in cervical cancer.
    Front Oncol. 2024;14:1371779.
    PubMed    
    Abstract available

  58. GAO T, Yang Z, Wei L, Tang X, et al
    Prognostic analysis of stage IIIC1p cervical cancer patients.
    Front Oncol. 2024;14:1362281.
    PubMed    
    Abstract available

  59. NISHIMURA H, Amano T, Yoneoka Y, Tsuji S, et al
    Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer.
    J Gynecol Oncol. 2024 May 1. doi: 10.3802/jgo.2025.
    PubMed    
    Abstract available

  60. DVORAK V, Petras M, Dvorak V, Lomozova D, et al
    Reduced risk of CIN2+ recurrence in women immunized with a 9-valent HPV vaccine post-excision: Retrospective cohort study.
    Hum Vaccin Immunother. 2024;20:2343552.
    PubMed    
    Abstract available

  61. DAI D, Pei Y, Zhu B, Wang D, et al
    Chemoradiotherapy-induced ACKR2(+) tumor cells drive CD8(+) T cell senescence and cervical cancer recurrence.
    Cell Rep Med. 2024 Apr 30:101550. doi: 10.1016/j.xcrm.2024.101550.
    PubMed    
    Abstract available

  62. LIU Q, Chen X, Tan Y, Liu J, et al
    Natural products as glycolytic inhibitors for cervical cancer treatment: A comprehensive review.
    Biomed Pharmacother. 2024;175:116708.
    PubMed    
    Abstract available

  63. SHASTRI SS, McNeill LH, Shete S
    Culturally Competent Education and Human Papillomavirus Self-Sampling Achieves Healthy People 2030 Cervical Screening Target Among Low-Income Non-Hispanic Black and Hispanic Women.
    JCO Glob Oncol. 2024;10:e2400005.
    PubMed    
    Abstract available

  64. MISHRA R, Singh S, Patel G, Mandal A, et al
    Comparative analysis of simultaneous integrated boost and sequential boost radiotherapy in node-positive cervical cancer: dosimetric and radiobiological considerations.
    Radiat Environ Biophys. 2024 May 9. doi: 10.1007/s00411-024-01069.
    PubMed    
    Abstract available

  65. LU X, Zhang W, Zhang J, Ren D, et al
    EPAS1, a hypoxia- and ferroptosis-related gene, promotes malignant behaviour of cervical cancer by ceRNA and super-enhancer.
    J Cell Mol Med. 2024;28:e18361.
    PubMed    
    Abstract available

  66. PICKERING AN, Zhao X, Sileanu FE, Lovelace EZ, et al
    Care cascades following low-value cervical cancer screening in dually enrolled Veterans.
    J Am Geriatr Soc. 2024 May 9. doi: 10.1111/jgs.18956.
    PubMed    
    Abstract available

  67. NESSA A, Islam T, Noor-E-Ferdousi NE, Sultana A, et al
    Staging and Management of Cervical Cancer at the Colposcopy Clinic of Bangabandhu Sheikh Sheikh Mujib Medical University (BSMMU), Bangladesh.
    South Asian J Cancer. 2024;13:17-26.
    PubMed    
    Abstract available

  68. TRAN J, Hathaway CL, Broshkevitch CJ, Palanee-Phillips T, et al
    Cost-effectiveness of single-visit cervical cancer screening in KwaZulu-Natal, South Africa: a model-based analysis accounting for the HIV epidemic.
    Front Oncol. 2024;14:1382599.
    PubMed    
    Abstract available

  69. ZHANG W, Yu H, Xiu Y, Meng F, et al
    Clinical Outcomes and Prognostic Factors in Stage III C Cervical Cancer Patients Treated with Radical Radiotherapy or Radiochemotherapy.
    Technol Cancer Res Treat. 2024;23:15330338241254075.
    PubMed    
    Abstract available

  70. KOBAYASHI N, Oike T, Ando K, Murata K, et al
    Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
    J Med Case Rep. 2024;18:228.
    PubMed    
    Abstract available

  71. WEI Y, Yu P, Zouyu Zhao, Sun C, et al
    Cervical Cancer Cell-derived Tie1 Expression Via PI3K/AKT Signaling Pathway Promotes Tumour Progression.
    Exp Cell Res. 2024 May 6:114060. doi: 10.1016/j.yexcr.2024.114060.
    PubMed    
    Abstract available

  72. LIU S, Wang Z, Hu L, Ye C, et al
    Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer.
    Transl Oncol. 2024;45:101982.
    PubMed    
    Abstract available

  73. RAJKHOWA P, Kalyanpur C, K R, Dsouza VS, et al
    Geospatial mapping of public sentiment and infodemic on human papillomavirus vaccination in India: An indication to formulation of strategies for effective implementation.
    Glob Public Health. 2024;19:2348646.
    PubMed    
    Abstract available

  74. LEE CY, Chen PN, Kao SH, Wu HH, et al
    Deoxyshikonin triggers apoptosis in cervical cancer cells through p38 MAPK-mediated caspase activation.
    Environ Toxicol. 2024 May 8. doi: 10.1002/tox.24323.
    PubMed    
    Abstract available

  75. GONZALEZ-RODRIGUEZ JC, Cruz-Valdez A, Madrid-Marina V
    Cervical cancer prevention by vaccination: review.
    Front Oncol. 2024;14:1386167.
    PubMed    
    Abstract available


  76. [Expert recommendation for real-world study on the application of human papillomavirus vaccine in the Yangtze River Delta region].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2024;58:577-587.
    PubMed    
    Abstract available

  77. PRESTON M, McBain R, Rajadevan N, Jones A, et al
    Sentinel lymph node detection with indocyanine green and patent blue dye in cervical cancer: A single-centre feasibility study.
    Aust N Z J Obstet Gynaecol. 2024 May 7. doi: 10.1111/ajo.13834.
    PubMed    
    Abstract available

  78. CHEN H, Zhou L, Fong D, Cun Y, et al
    Quality of life and its related-influencing factors in patients with cervical cancer based on the scale QLICP-CE(V2.0).
    BMC Womens Health. 2024;24:277.
    PubMed    
    Abstract available

  79. VEMULA VENKATA VL, Hulikal N, Chowhan AK
    Effectiveness of sentinel lymph node biopsy and bilateral pelvic nodal dissection using methylene blue dye in early-stage operable cervical cancer-A prospective study.
    Cancer Treat Res Commun. 2024;39:100816.
    PubMed    
    Abstract available

  80. ZHANG W, Wang H, Chen S, Fan X, et al
    Reactivation of methylation-silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway.
    Mol Carcinog. 2024 May 7. doi: 10.1002/mc.23728.
    PubMed    
    Abstract available

  81. NARCISSE MR, McElfish PA, Hallgren E, Pierre-Joseph N, et al
    Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States.
    Front Public Health. 2024;12:1321253.
    PubMed    
    Abstract available

  82. ZENG F, Guo P, Xia M, He M, et al
    Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
    J Cancer Res Clin Oncol. 2024;150:236.
    PubMed    
    Abstract available

  83. HE H, He M, Zhou Q, Tang Y, et al
    Genetic analysis of cervical cancer with lymph node metastasis.
    J Gynecol Oncol. 2024 Apr 29. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  84. PENG Q, Li Y, Li J, Yao X, et al
    [Research progress on the differences between T and B cell responses to three different forms of human papilloma virus (HPV) vaccination].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024;40:378-382.
    PubMed    
    Abstract available

  85. XU Y, Gao L, Yang J, Wang J, et al
    [Knockdown mitochondrial transcription factor A (TFAM) inhibits autophagy, proliferation, invasion and migration in human cervical cancer and osteosarcoma cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024;40:311-318.
    PubMed    
    Abstract available

  86. ZHANG A, Zheng X, Chen S, Duan G, et al
    In vitro study of HPV18-positive cervical cancer HeLa cells based on CRISPR/Cas13a system.
    Gene. 2024;921:148527.
    PubMed    
    Abstract available

  87. FISHER A, Long JR, Chor J
    Closing the Cervical Cancer Screening Gap-Reaching Sexual and Gender Diverse Populations.
    JAMA Netw Open. 2024;7:e248855.
    PubMed    


  88. BAUMANN K, Matzke H, Peterson CE, Geller S, et al
    Sexual Orientation and Cervical Cancer Screening Among Cisgender Women.
    JAMA Netw Open. 2024;7:e248886.
    PubMed    
    Abstract available

  89. ZHAO N, Li Y, Chen X, Ma J, et al
    Evaluating the clinical efficacy and safety of concurrent chemoradiotherapy with cisplatin and nab-paclitaxel in postoperative early-stage cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:233.
    PubMed    
    Abstract available

  90. LIU L, Lei H, Hou G, Zhang L, et al
    Gas-Amplified Metalloimmunotherapy with Dual Activation of Pyroptosis and the STING Pathway for Remodeling the Immunosuppressive Cervical Cancer Microenvironment.
    ACS Nano. 2024 May 6. doi: 10.1021/acsnano.4c00017.
    PubMed    
    Abstract available

  91. XIONG G, Shan J, Chong Q, Cui Y, et al
    Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma.
    Aging (Albany NY). 2024;16:6898-6920.
    PubMed    
    Abstract available

  92. COSTANZI JM, Stosic MS, Lovestad AH, Ambur OH, et al
    Changes in intrahost genetic diversity according to lesion severity in longitudinal HPV16 samples.
    J Med Virol. 2024;96:e29641.
    PubMed    
    Abstract available

  93. NEWTON C, Graham R, Liberale V, Burnell M, et al
    Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
    J Obstet Gynaecol. 2024;44:2344529.
    PubMed    
    Abstract available

  94. ADAMS RA, Visser C, Dreyer G, Snyman L, et al
    Sociodemographics, behaviour and knowledge of first South African HPV-vaccine recipients.
    S Afr Fam Pract (2004). 2024;66:e1-e6.
    PubMed    
    Abstract available

  95. SAHIN G, Duran T, Afsar S, Kebapcilar A, et al
    The antitumoral effect of the esculetin in HeLa cells through endoplasmic reticulum stress.
    Eur Rev Med Pharmacol Sci. 2024;28:3048-3055.
    PubMed    
    Abstract available

  96. KUNATOGA A, Mohammadnezhad M, Khan S, Naeem P, et al
    Prevalence and trends of cervical cancer screening among women in Fiji from 2014 to 2018.
    Heliyon. 2024;10:e30220.
    PubMed    
    Abstract available

  97. CHEN W, Zhang N, He Z, Li Q, et al
    The efficacy of immune checkpoint inhibitors on low PD-L1 cervical cancer: A meta-analysis.
    Health Sci Rep. 2024;7:e2069.
    PubMed    
    Abstract available

  98. YU X, Dong S, Wang W, Sun X, et al
    Case report: A case of recurrent cervical cancer with bronchial and esophageal metastases presenting with hemoptysis and dysphagia.
    Front Oncol. 2024;14:1375035.
    PubMed    
    Abstract available

  99. SALTA S, Sequeira JP, Lobo J, Sousa A, et al
    Preliminary outcomes of the Cervical Cancer Screening Program of Northern Portugal: A snapshot.
    J Infect Public Health. 2024;17:1057-1064.
    PubMed    
    Abstract available

  100. SANTANA OTANO S, Mendes Melo A, Ferreira Souza B, Souto Morlin J, et al
    Peritumoral stroma and systemic inflammatory response in cervical cancer.
    Ceska Gynekol. 2024;89:95-101.
    PubMed    
    Abstract available

  101. PROWSE SR, Brazzelli M, Treweek S
    What factors influence the uptake of bowel, breast and cervical cancer screening? An overview of international research.
    Eur J Public Health. 2024 May 3:ckae073. doi: 10.1093.
    PubMed    
    Abstract available

  102. TEKLEHAIMANOT DA, Mekuria AD, Dadi AF, Derseh BT, et al
    Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study.
    BMC Womens Health. 2024;24:271.
    PubMed    
    Abstract available

  103. MOOSES K, Savrova A, Pajusalu M, Oja M, et al
    Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: A cross-sectional study.
    Prev Med. 2024;183:107982.
    PubMed    
    Abstract available

  104. GARG P, Krishna M, Subbalakshmi AR, Ramisetty S, et al
    Emerging biomarkers and molecular targets for precision medicine in cervical cancer.
    Biochim Biophys Acta Rev Cancer. 2024;1879:189106.
    PubMed    
    Abstract available

  105. LIU HT, Zhao Y, Wang HC, Liu QL, et al
    METTL3-mediated m(6)A methylation of SLC38A1 stimulates cervical cancer growth.
    Biochem Biophys Res Commun. 2024;716:150039.
    PubMed    
    Abstract available

  106. WANG Y, Han Y, Jin L, Ji L, et al
    A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Aging (Albany NY). 2024;16:7293-7310.
    PubMed    
    Abstract available

  107. FELICELLI C, Smith SH, Griffin B, Grubs A, et al
    The Silva pattern-based classification for HPV-associated endocervical adenocarcinoma: A single institution concordance study of trainees and gynecologic pathologists.
    Pathol Res Pract. 2024;257:155311.
    PubMed    
    Abstract available

  108. LORENSET LC, Percicote AP, Munhos SHO, Zanine RM, et al
    Reevaluation of negative cervical conizations: Frequency, diagnostic errors, risk factors and management.
    Pathol Res Pract. 2024;257:155283.
    PubMed    
    Abstract available

  109. LIN LH, Howitt BE, Kolin DL
    From morphology to methylome: epigenetic studies of Mullerian mesonephric-like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma(dagger).
    J Pathol. 2024;263:135-138.
    PubMed    
    Abstract available

  110. KASHYAP A, Kumari M, Singh A, Mukherjee K, et al
    Current development of theragnostic nanoparticles for women's cancer treatment.
    Biomed Mater. 2024;19.
    PubMed    
    Abstract available

  111. PENG X, Wang B, Li X, Li Y, et al
    Correlates of sexual and reproductive health service utilization among older adults in China: Findings from the sexual well-being (SWELL) study.
    Maturitas. 2024;184:107965.
    PubMed    
    Abstract available

  112. KIZILTAS S, Topaloglu Oren ED
    Levels of depression and self-esteem in women with cancer of the endometrium and cervix receiving chemotherapy treatment in Turkiye.
    Enferm Clin (Engl Ed). 2024;34:96-107.
    PubMed    
    Abstract available

  113. HA K, Sheets K, Kedar R, Gooden C, et al
    Primary Cervical Lymphoma Mimicking Deep Endometriosis.
    J Minim Invasive Gynecol. 2024;31:357-359.
    PubMed    


  114. AUGUSTOVSKI F, Argento F, Alcaraz A, Garcia Marti S, et al
    Toward the Implementation of a Value Framework for Diagnostic Technologies: Operationalization, Piloting, and Validation in Latin America.
    Value Health. 2024;27:570-577.
    PubMed    
    Abstract available

  115. NISHIO H, Matsuda R, Iwata T, Yamagami W, et al
    Gastric-type adenocarcinoma of the uterine cervix: clinical features and future directions.
    Jpn J Clin Oncol. 2024;54:516-520.
    PubMed    
    Abstract available

  116. TAN CY, Yang QL, Xu N, Wang HJ, et al
    Small-cell neuroendocrine carcinoma of the cervix: An analysis of 5 cases and literature review.
    Asian J Surg. 2024;47:2508-2509.
    PubMed    


  117. SINGH AK, Walavalkar K, Tavernari D, Ciriello G, et al
    Cis-regulatory effect of HPV integration is constrained by host chromatin architecture in cervical cancers.
    Mol Oncol. 2024;18:1189-1208.
    PubMed    
    Abstract available

  118. WALLER J, Waite F, Marlow L
    Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey.
    J Med Screen. 2024;31:91-98.
    PubMed    
    Abstract available

  119. PENG J, Chen Y, Yin A
    JAM3 promotes cervical cancer metastasis by activating the HIF-1alpha/VEGFA pathway.
    BMC Womens Health. 2024;24:293.
    PubMed    
    Abstract available

  120. HALLE MK, Hodneland E, Wagner-Larsen KS, Lura NG, et al
    Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.
    Sci Rep. 2024;14:11339.
    PubMed    
    Abstract available

  121. SAHASRABUDDHE VV
    Cervical Cancer: Precursors and Prevention.
    Hematol Oncol Clin North Am. 2024 May 16:S0889-8588(24)00032.
    PubMed    
    Abstract available

  122. BOJE RB, Bardou M, Mensah K, Rico Berrocal R, et al
    What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries.
    BMJ Open. 2024;14:e079921.
    PubMed    
    Abstract available

  123. REICH O, Regauer S
    Understanding the age-related epithelial shifts at the uterine cervix and the area of risk for squamous cell cervical cancer.
    Prev Med. 2024 May 15:108006. doi: 10.1016/j.ypmed.2024.108006.
    PubMed    


  124. QIN J, Chen Y, Zhao X, Yu J, et al
    circCUL3 drives malignant progression of cervical cancer by activating autophagy through sponge miR-223-3p upregulation of ATG7.
    Gene. 2024 May 15:148572. doi: 10.1016/j.gene.2024.148572.
    PubMed    
    Abstract available

  125. DEVI S, Gangarde R, Deokar S, Muqeemuddin SF, et al
    Public health nurse perspectives on predicting nonattendance for cervical cancer screening through classification, ensemble, and deep learning models.
    Public Health Nurs. 2024 May 17. doi: 10.1111/phn.13334.
    PubMed    
    Abstract available

  126. PARLAK B, Ugurlucan FG, Gokcay EG
    Actions speak louder than words; pediatricians, gynecologists, nurses, and other mothers' perspectives on the human papillomavirus vaccine: an Istanbul multicenter study.
    Front Public Health. 2024;12:1361509.
    PubMed    
    Abstract available

  127. ZHU X, Feng Y, Fan P, Dong D, et al
    Increased co-expression of 4-1BB with PD-1 on CD8+ tumor-infiltrating lymphocytes is associated with improved prognosis and immunotherapy response in cervical cancer.
    Front Oncol. 2024;14:1381381.
    PubMed    
    Abstract available

  128. SATHISHKUMAR K, Sankarapillai J, Mathew A, Nair RA, et al
    Survival of patients with cervical cancer in India - findings from 11 population based cancer registries under National Cancer Registry Programme.
    Lancet Reg Health Southeast Asia. 2023;24:100296.
    PubMed    
    Abstract available

  129. ZHANG M, Chen J, Cui M, Jia J, et al
    Analysis of the global burden of cervical cancer in young women aged 15-44 years old.
    Eur J Public Health. 2024 May 16:ckae084. doi: 10.1093.
    PubMed    
    Abstract available

  130. ZHANG Z, Zhou X, Li J, Meng Q, et al
    LncRNA HOTAIR promotes the migration and invasion of cervical cancer through DNMT3B/LATS1/ YAP1 pS127 axis.
    Reprod Biol. 2024;24:100893.
    PubMed    
    Abstract available

  131. BACORRO W, Short M, Baldivia K, Mariano J, et al
    Shared Decision Making in Oncology and Its Implementation in Cervical Cancer Management in the Philippines: A Narrative Review.
    JCO Glob Oncol. 2024;10:e2300486.
    PubMed    
    Abstract available

  132. LI XX, Liu B, Cui Y, Zhao YF, et al
    Intravoxel incoherent motion diffusion-weighted imaging and dynamic contrast-enhanced MRI for predicting parametrial invasion in cervical cancer.
    Abdom Radiol (NY). 2024 May 16. doi: 10.1007/s00261-024-04339.
    PubMed    
    Abstract available

  133. FARIA PCL, Resende RS, Cardoso AM
    Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets.
    Purinergic Signal. 2024 May 16. doi: 10.1007/s11302-024-10020.
    PubMed    
    Abstract available

  134. CHENG Q, Fan S, Xu J, Zhou H, et al
    Analysis of the impact of introspective therapy on the psychological state and family functioning of cervical cancer patients with anxiety.
    Minerva Med. 2024 May 15. doi: 10.23736/S0026-4806.24.09256.
    PubMed    


  135. CHOWDHURY MZI, Mubin N, Mohib T, Chowdhury N, et al
    Cancer screening research in Bangladesh: Insights from a scoping review.
    Glob Public Health. 2024;19:2351186.
    PubMed    
    Abstract available

  136. SHANMUGAM A, Kvn K, Radhabai PR, Natarajan S, et al
    HO-SsNF: heap optimizer-based self-systematized neural fuzzy approach for cervical cancer classification using pap smear images.
    Front Oncol. 2024;14:1264611.
    PubMed    
    Abstract available

  137. IDRAK S, Zaki S, Rasheed F, Javed M, et al
    Cervical cancer screening practices in HIV positive females - a missing link in health care delivery in Pakistan.
    J Pak Med Assoc. 2024;74:631-640.
    PubMed    
    Abstract available

  138. RIZZO A, Dalu D, Moschese D, Giacomelli A, et al
    Eliminating cervical cancer: Don't forget HPV test and vaccination in men.
    J Med Virol. 2024;96:e29677.
    PubMed    


  139. WANG Y, Wang X, Liu Y, He Y, et al
    HPV16-miRNAs exert oncogenic effects through enhancers in human cervical cancer.
    Cancer Cell Int. 2024;24:172.
    PubMed    
    Abstract available

  140. FUJII T, Nishio E, Tsukamoto T, Kukimoto I, et al
    Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus.
    Cancer Sci. 2024 May 15. doi: 10.1111/cas.16214.
    PubMed    
    Abstract available

  141. AMBOREE TL, Paguio J, Sonawane K
    HPV vaccine: the key to eliminating cervical cancer inequities.
    BMJ. 2024;385:q996.
    PubMed    


  142. FALCARO M, Soldan K, Ndlela B, Sasieni P, et al
    Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.
    BMJ. 2024;385:e077341.
    PubMed    
    Abstract available

  143. CHENG J, Zhao B, Liu Z, Huang D, et al
    DMGM: deformable-mechanism based cervical cancer staging via MRI multi-sequence.
    Phys Med Biol. 2024 May 15. doi: 10.1088/1361-6560.
    PubMed    
    Abstract available

  144. ZHANG R, Bai J, Wang R, Yan J, et al
    Quantified difference of the collapsed cone convolution (CCC) and Monte Carlo (MC) algorithms based on DVH and gamma analysis for cervical cancer radiation therapy.
    Appl Radiat Isot. 2024;210:111340.
    PubMed    
    Abstract available

  145. PLANTE M, Mahner S, Ferron G
    Simple versus Radical Hysterectomy for Low-Risk Cervical Cancer. Reply.
    N Engl J Med. 2024;390:1833.
    PubMed    


  146. CIBULA D, Falconer H, Kohler C
    Simple versus Radical Hysterectomy for Low-Risk Cervical Cancer.
    N Engl J Med. 2024;390:1832-1833.
    PubMed    


  147. SONG H, Jiang H, Hu W, Hai Y, et al
    Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids.
    Sci Adv. 2024;10:eadl3511.
    PubMed    
    Abstract available

  148. ZHOU W, Song W, Lu M
    circ_0006789 promotes cervical cancer development via the miR-615-5p/HSF1 axis.
    Discov Oncol. 2024;15:165.
    PubMed    
    Abstract available

  149. ZENG S, Xiao S, Xu Y, Yang P, et al
    Efficacy and safety analysis of non-radical surgery for early-stage cervical cancer (IA2 ~ IB1): a systematic review and meta-analysis.
    Front Med (Lausanne). 2024;11:1337752.
    PubMed    
    Abstract available

  150. WANG M, Liang H, Yan Y, Bian R, et al
    Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review.
    Hum Vaccin Immunother. 2024;20:2343192.
    PubMed    
    Abstract available

  151. HOU PX, Fan Q, Zhang Q, Liu JJ, et al
    M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
    Clin Exp Pharmacol Physiol. 2024;51:e13868.
    PubMed    
    Abstract available

  152. LAMI A, Alvisi S, Siconolfi A, Seracchioli R, et al
    Primary and secondary prevention of cervical cancer among Italian AFAB transgender people.
    Curr Probl Cancer. 2024;50:101103.
    PubMed    
    Abstract available

  153. JIN R, Li H, Nan S, Wang H, et al
    FOXA1 co-activates circODC1 and ODC1 in HPV-positive cervical cancer cell growth.
    Syst Biol Reprod Med. 2024;70:113-123.
    PubMed    
    Abstract available

  154. KASSA RN, Shifti DM, Alemu K, Omigbodun AO, et al
    Integration of cervical cancer screening into healthcare facilities in low- and middle-income countries: A scoping review.
    PLOS Glob Public Health. 2024;4:e0003183.
    PubMed    
    Abstract available

  155. MATHOMA A, Sartorius B, Mahomed S
    Evaluation of cancer screening services provided for people living with HIV in Botswana, 2022-2023.
    Health Promot Int. 2024;39:daae042.
    PubMed    
    Abstract available

  156. PIOTROWSKI PG, Jelen MT
    Retrospective analysis of negative cytology results correlated with a positive high-risk in the human papillomavirus result and subsequent results of patients over a period of three years.
    Pol J Pathol. 2024;75:36-39.
    PubMed    
    Abstract available

  157. LAN C, Lu H, Zhou L, Liao K, et al
    Long-term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study.
    Cancer Commun (Lond). 2024 May 13. doi: 10.1002/cac2.12547.
    PubMed    
    Abstract available

  158. GUILLEN-MELENDEZ GA, Perez-Hernandez RA, Chavez-Montes A, Castillo-Velazquez U, et al
    Nanoencapsulation of Extracts and Isolated Compounds of Plant Origin and Their Cytotoxic Effects on Breast and Cervical Cancer Treatments: Advantages and New Challenges.
    Toxicon. 2024 May 11:107753. doi: 10.1016/j.toxicon.2024.107753.
    PubMed    
    Abstract available

  159. MIYATA Y, Ogo E, Murotani K, Tsuda N, et al
    Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the 'adjusted dose score'.
    J Radiat Res. 2024 May 13:rrae031. doi: 10.1093.
    PubMed    
    Abstract available

  160. LI L, Zeng J, He S, Yang Y, et al
    METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer.
    Cancer Biol Ther. 2024;25:2349429.
    PubMed    
    Abstract available

  161. HE JY, Li ZM, Chen YT, Zhao BH, et al
    Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database.
    Transl Cancer Res. 2024;13:1721-1736.
    PubMed    
    Abstract available

  162. ZOU J, Li Y, Chen T, Zhu C, et al
    An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer.
    Transl Cancer Res. 2024;13:1876-1886.
    PubMed    
    Abstract available

  163. CHEN X, Sun Y, Li F, Xi L, et al
    (68)Ga-labeled TMTP1 radiotracer for PET imaging of cervical cancer.
    Am J Nucl Med Mol Imaging. 2024;14:110-121.
    PubMed    
    Abstract available

  164. CHEN J, Zhang R, Xu W, Bai L, et al
    Correction: Knowledge and Practices Regarding Human Papillomavirus and Cervical Cancer Screening Among Women in Low-Income Areas of China: A Cross-Sectional Study.
    Cureus. 2024;16:c174.
    PubMed    
    Abstract available

  165. KURDOGLU M, Kurdoglu Z, Kucukaydin Z, Erten R, et al
    Laminin receptor 1 expression in premalignant and malignant squamous lesions of the cervix.
    Biotech Histochem. 2024;99:174-181.
    PubMed    
    Abstract available

  166. LI J, Adobo SD, Shi H, Judicael KAW, et al
    Screening Methods for Cervical Cancer.
    ChemMedChem. 2024 May 12:e202400021. doi: 10.1002/cmdc.202400021.
    PubMed    
    Abstract available

  167. HUANG M, Hu J, Chen Y, Xun Y, et al
    Mesencephalic astrocyte-derived neurotrophic factor inhibits cervical cancer progression via regulating macrophage phenotype.
    Mol Biol Rep. 2024;51:654.
    PubMed    
    Abstract available

  168. MATHIVANAN SK, Francis D, Srinivasan S, Khatavkar V, et al
    Enhancing cervical cancer detection and robust classification through a fusion of deep learning models.
    Sci Rep. 2024;14:10812.
    PubMed    
    Abstract available

  169. SPORT C, Yarden N, Bale C, Mukhodpadhyay N, et al
    To who and by who: Discussions of sexual health, fertility, and premature menopause with women with locally advanced cervical cancer.
    Brachytherapy. 2024 May 10:S1538-4721(24)00066.
    PubMed    
    Abstract available

  170. KONG X, Xiong Y, Li L
    LINC01605 promotes malignant phenotypes of cervical cancer via miR-149-3p/WNT7B axis.
    Gene. 2024;921:148518.
    PubMed    
    Abstract available

  171. TESFAYE W, Ashine B, Yimer Y, Yismaw Y, et al
    Utilization of cervical cancer screening and determinant factors among female nurses in selected public hospitals in Addis Ababa, Ethiopia.
    Cancer Treat Res Commun. 2024;40:100815.
    PubMed    
    Abstract available

  172. SU M, Liang Z, Shan S, Gao Y, et al
    Long non-coding RNA NEAT1 promotes aerobic glycolysis and progression of cervical cancer through WNT/beta-catenin/PDK1 axis.
    Cancer Med. 2024;13:e7221.
    PubMed    
    Abstract available

  173. ZHANG L, Liu W, Li Y, Fu Y, et al
    Polyphyllin I Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment.
    Nutr Cancer. 2024 May 10:1-10. doi: 10.1080/01635581.2024.2350107.
    PubMed    
    Abstract available

  174. MARK ZA, Yu L, Castro L, Gao X, et al
    Tobacco Smoke Condensate Induces Morphologic Changes in Human Papillomavirus-Positive Cervical Epithelial Cells Consistent with Epithelial to Mesenchymal Transition (EMT) with Activation of Receptor Tyrosine Kinases and Regulation of TGFB.
    Int J Mol Sci. 2024;25:4902.
    PubMed    
    Abstract available

  175. MALLMANN MR, Tamir S, Alfter K, Ratiu D, et al
    Expression of Potential Antibody-Drug Conjugate Targets in Cervical Cancer.
    Cancers (Basel). 2024;16:1787.
    PubMed    
    Abstract available

  176. WEAVER C, Nam A, Settle C, Overton M, et al
    Serum Proteomic Signatures in Cervical Cancer: Current Status and Future Directions.
    Cancers (Basel). 2024;16:1629.
    PubMed    
    Abstract available

  177. FAN Q, Ding H, Mo H, Tang Y, et al
    Cervical cancer biomarker screening based on Raman spectroscopy and multivariate statistical analysis.
    Spectrochim Acta A Mol Biomol Spectrosc. 2024;317:124402.
    PubMed    
    Abstract available

  178. ZHANG X, Yan W, Chen X, Li X, et al
    Long-term 4-nonylphenol exposure drives cervical cell malignancy through MAPK-mediated ferroptosis inhibition.
    J Hazard Mater. 2024;471:134371.
    PubMed    
    Abstract available

  179. CHEN Z, Liu W, Liu K, Wang S, et al
    Double-layer hollow mesoporous silica nanoparticles for ultrasound-guided photodynamic treatment.
    Biomed Mater. 2024;19.
    PubMed    
    Abstract available

  180. STENHOUSE K, Roumeliotis M, Ciunkiewicz P, Martell K, et al
    Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy.
    Brachytherapy. 2024;23:368-376.
    PubMed    
    Abstract available

  181. LAI TS, Francoeur A, Manrriquez E, Venkat P, et al
    Percutaneous interstitial brachytherapy ablation for targeting oligometastatic gynecologic cancers.
    Brachytherapy. 2024;23:266-273.
    PubMed    
    Abstract available

  182. JIAO XF, Li H, Zeng L, Yang H, et al
    Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank.
    Eur J Clin Pharmacol. 2024;80:855-867.
    PubMed    
    Abstract available

  183. CHEN P, Zhang X, Fang Q, Zhao Z, et al
    Betulinic acid induces apoptosis of HeLa cells via ROS-dependent ER stress and autophagy in vitro and in vivo.
    J Nat Med. 2024;78:677-692.
    PubMed    
    Abstract available

  184. EWONGWO A, Niedermayr T, Kidd EA
    Design approach and benefits of the 3D-printed vaginal individualized applicator (VIA).
    Brachytherapy. 2024;23:282-289.
    PubMed    
    Abstract available

  185. GOETZ LH, Evans HL, Armylagos D, Zhou H, et al
    Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testing.
    J Am Soc Cytopathol. 2024;13:227-232.
    PubMed    
    Abstract available

  186. ROACH E, Hutten R, Johnson S, Suneja G, et al
    The impact of a positive COVID-19 test on timeliness of radiation in patients receiving brachytherapy.
    Brachytherapy. 2024;23:360-367.
    PubMed    
    Abstract available

  187. NASU H, Nishio S, Park J, Tasaki K, et al
    Comprehensive Molecular Profiling and Clinicopathological Characteristics of Gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women.
    Kurume Med J. 2024;69.
    PubMed    
    Abstract available

  188. HUANG J, Zhao Y
    Effect of GLIS1 on the Lymph Node Metastasis of Cervical Squamous Carcinoma Based on Transcriptome Analysis.
    Reprod Sci. 2024;31:1332-1344.
    PubMed    
    Abstract available

  189. LIU Y, Dong TF, Li PJ, Chen LB, et al
    MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
    Magn Reson Imaging. 2023 Nov 28:S0730-725X(23)00198.
    PubMed    
    Abstract available

  190. JARA FERNANDEZ L, Ferrer JA, Perez Calle JL, Lopez Serrano P, et al
    Is cervical dysplasia a major concern in females with inflammatory bowel disease? A Spanish retrospective study.
    Rev Esp Enferm Dig. 2024;116:292-293.
    PubMed    
    Abstract available

  191. CHAN DNS, Lee PPK, So WKW
    Exploring the Barriers and Facilitators Influencing Human Papillomavirus Vaccination Decisions Among South Asian and Chinese Mothers: a Qualitative Study.
    J Racial Ethn Health Disparities. 2024;11:1465-1477.
    PubMed    
    Abstract available

  192. ADEBOLA A, Adaeze A, Adeyimika D, Lovoria WB, et al
    Experiences and Challenges of African American and Sub-Saharan African Immigrant Black Women in Completing Pap Screening: a Mixed Methods Study.
    J Racial Ethn Health Disparities. 2024;11:1405-1417.
    PubMed    
    Abstract available

  193. SHETH SS, Oh JE, Bellone S, Siegel ER, et al
    Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
    Clin Cancer Res. 2024;30:1768-1777.
    PubMed    
    Abstract available

  194. WANG D, Fang X
    Meta-analysis of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:202-208.
    PubMed    
    Abstract available

  195. CHIBA Y, Kojima Y, Yazaki S, Yoshida H, et al
    Trop-2 expression and the tumor immune microenvironment in cervical cancer.
    Gynecol Oncol. 2024;187:51-57.
    PubMed    
    Abstract available

  196. HUNSBERGER KS, Treiman S, Monk BJ, Tewari KS, et al
    A systematic review of stage IVA cervical cancer treatment: Challenges in the management of an understudied group.
    Gynecol Oncol. 2024;187:120-127.
    PubMed    
    Abstract available

  197. GILHAM C, Nedjai B, Scibior-Bentkowska D, Reuter C, et al
    Long-term prediction by DNA methylation of high-grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort.
    Int J Cancer. 2024;155:81-92.
    PubMed    
    Abstract available

  198. LINDQUIST S, Frederiksen K, Petersen LK, Kjaer SK, et al
    The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Int J Cancer. 2024 Feb 28. doi: 10.1002/ijc.34896.
    PubMed    
    Abstract available

  199. HANSEN BT, Nygard M, Castle PE, Burger EA, et al
    Sociodemographic characteristics associated with cervical cancer screening participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results from a randomized controlled trial among long-term non-attending women in Norway.
    Int J Cancer. 2024 May 15. doi: 10.1002/ijc.34989.
    PubMed    
    Abstract available

  200. MWANDACHA N, Dau H, AboMoslim M, Naguti P, et al
    Investigating the healthcare-seeking behaviors of mobile phone users to improve cervical cancer screening in rural Uganda.
    Int J Gynaecol Obstet. 2024 May 4. doi: 10.1002/ijgo.15577.
    PubMed    
    Abstract available

  201. YANG ST, Liu HH, Liu CH, Wang LW, et al
    Bevacizumab is associated with a higher gastrointestinal/genitourinary fistula or perforation risk in cervical cancer patients undergoing pelvic radiotherapy.
    Int J Gynaecol Obstet. 2024 May 15. doi: 10.1002/ijgo.15609.
    PubMed    
    Abstract available

  202. WANG R, Ma L, Xiao Y, Jiang H, et al
    A case of postoperative non-invasive mucosal implantation of early-stage cervical adenocarcinoma to the clitoris.
    Int J Gynaecol Obstet. 2024;165:1295-1297.
    PubMed    


  203. SHI V, Grover S, Huang Y, Thaker PH, et al
    Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
    Int J Gynecol Cancer. 2024 Apr 29:ijgc-2024-005303.
    PubMed    
    Abstract available

  204. ZHU J, Li X, Huang M, Zhu H, et al
    Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multi-center, Randomized, Open-label, Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2024 May 3:S0360-3016(24)00611.
    PubMed    
    Abstract available

  205. POLJAK M, Ostrbenk Valencak A, Cuschieri K, Bohinc KB, et al
    2023 global inventory of commercial molecular tests for human papillomaviruses (HPV).
    J Clin Virol. 2024;172:105671.
    PubMed    
    Abstract available

  206. LI W, Liang J, Zhang Z, Lou H, et al
    [Retracted] MicroRNA?329?3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
    Oncol Rep. 2024;51:86.
    PubMed    
    Abstract available

  207. ZHOU Y, Wang W, Tang J, Hu K, et al
    Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    BMC Cancer. 2024;24:548.
    PubMed    
    Abstract available

  208. LEI L, Zhang L, Zheng Y, Ma W, et al
    Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    BMC Cancer. 2024;24:575.
    PubMed    
    Abstract available

  209. ZHAO A, Pan Y, Gao Y, Zhi Z, et al
    MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3.
    BMC Cancer. 2024;24:559.
    PubMed    
    Abstract available

  210. LYONNAIS E, Vigoureux S, Blondel B, Wylomanski S, et al
    Women's country of birth and failure to catch up an overdue cervical cancer cytological screening participation during pregnancy in France, an observational study based on survey sources.
    BMC Cancer. 2024;24:595.
    PubMed    
    Abstract available

  211. WU Y, Jiang P, Chen Z, Li W, et al
    Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    BMC Cancer. 2024;24:589.
    PubMed    
    Abstract available

  212. WANG QL, Gong C, Meng XY, Fu M, et al
    TPP1 is associated with risk of advanced precursors and cervical cancer survival.
    PLoS One. 2024;19:e0298118.
    PubMed    
    Abstract available

  213. SHIMELS T, Gashawbeza B, Fenta TG
    Validation of the Amharic version of perceived access to healthcare services for patients with cervical cancer in Ethiopia: A second-order confirmatory factor analysis.
    PLoS One. 2024;19:e0300815.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;